{"data":{"id":"us-nv/nrs-689c.16805","jurisdiction":"us-nv","citation":"NRS 689C.16805","heading":"Limitation on cost-sharing obligation for insulin covered by plan covering prescription insulin drugs; prohibited acts.","body":"1. A carrier that offers or issues a health benefit plan which provides coverage for prescription insulin drugs shall not impose against an insured a deductible, copayment, coinsurance or other cost-sharing obligation that is greater than $35 for a 30-day supply of a prescription insulin drug which is prescribed to the insured and covered by the carrier, regardless of the amount or type of prescription insulin drug prescribed.\n2. As used in this section:\n(a) “Diabetes” includes type I, type II and gestational diabetes.\n(b) “Prescription insulin drug” means a prescription drug that contains insulin and is used to control blood glucose levels for the purpose of treating diabetes.","path":["TITLE 57 — INSURANCE","CHAPTER 689C - HEALTH INSURANCE FOR SMALL EMPLOYERS","HEALTH BENEFIT PLANS"],"source_url":"https://www.leg.state.nv.us/NRS/NRS-689C.html#NRS689CSec16805","current_through":"2025 session (NRS as revised 2026-08-25)","vintage":"","retrieved_at":"2026-09-03T05:51:46Z","sha256":"8d7810ea75b5f43713340c5ba3815a30a2c728c9addce998748158eaacb227d5","source_id":"us-nv","stale":true,"prev":"us-nv/nrs-689c.168","next":"us-nv/nrs-689c.1681"},"notice":"GroundRules: Original legal text. Not legal advice."}